LHC Group (NASDAQ:LHCG) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

According to Zacks, “LHC Group provides post-acute healthcare services primarily to Medicare beneficiaries in rural markets in the southern United States. They provide home-based services through their home nursing agencies and hospices and facility-based services through their long-term acute care hospitals and outpatient rehabilitation clinics. “

A number of other research firms have also recently issued reports on LHCG. Royal Bank Of Canada cut LHC Group from an “outperform” rating to a “sector perform” rating and raised their target price for the company from $44.00 to $58.00 in a research note on Friday, March 10th. Craig Hallum set a $57.00 price target on LHC Group and gave the company a “buy” rating in a report on Saturday, March 11th. Oppenheimer Holdings, Inc. reissued an “outperform” rating and set a $68.00 price target (up from $55.00) on shares of LHC Group in a report on Monday, May 8th. SunTrust Banks, Inc. raised LHC Group from a “hold” rating to a “buy” rating and raised their price target for the company from $50.00 to $56.00 in a report on Friday, March 10th. Finally, Jefferies Group LLC lifted their target price on LHC Group from $56.00 to $65.00 and gave the stock a “buy” rating in a report on Monday, May 15th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $64.38.

Shares of LHC Group (LHCG) traded up 1.25% during trading on Thursday, reaching $66.48. 78,091 shares of the company’s stock traded hands. LHC Group has a 1-year low of $32.04 and a 1-year high of $69.35. The company has a 50 day moving average of $63.33 and a 200-day moving average of $53.11. The company has a market capitalization of $1.22 billion, a price-to-earnings ratio of 30.78 and a beta of 0.80.

TRADEMARK VIOLATION NOTICE: This news story was reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another domain, it was stolen and republished in violation of international copyright and trademark laws. The original version of this news story can be read at https://www.americanbankingnews.com/2017/07/09/lhc-group-lhcg-downgraded-by-zacks-investment-research.html.

In related news, Director Coliseum Capital Management, L sold 128,000 shares of LHC Group stock in a transaction dated Thursday, May 11th. The stock was sold at an average price of $60.99, for a total value of $7,806,720.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Donald Dwayne Stelly sold 3,181 shares of LHC Group stock in a transaction dated Thursday, June 8th. The stock was sold at an average price of $64.97, for a total value of $206,669.57. Following the completion of the transaction, the chief operating officer now directly owns 114,235 shares in the company, valued at approximately $7,421,847.95. The disclosure for this sale can be found here. Insiders sold a total of 682,839 shares of company stock worth $42,140,531 in the last three months. 14.80% of the stock is currently owned by company insiders.

Institutional investors have recently modified their holdings of the company. Russell Investments Group Ltd. bought a new position in shares of LHC Group during the fourth quarter worth $1,535,000. Swiss National Bank raised its stake in shares of LHC Group by 2.8% in the first quarter. Swiss National Bank now owns 25,535 shares of the health services provider’s stock worth $1,376,000 after buying an additional 700 shares during the last quarter. Norges Bank acquired a new stake in shares of LHC Group during the fourth quarter worth approximately $7,913,000. Sawgrass Asset Management LLC acquired a new stake in shares of LHC Group during the first quarter worth approximately $241,000. Finally, State Street Corp raised its stake in shares of LHC Group by 7.8% in the fourth quarter. State Street Corp now owns 373,936 shares of the health services provider’s stock worth $17,094,000 after buying an additional 26,915 shares during the last quarter. 84.75% of the stock is currently owned by hedge funds and other institutional investors.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.